Delivery Order SPE2DB22D9143-SPE2DB25FZC64
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency for $18.6K to supply Photrexa Cross-Linking Kit 6ML, with an ultimate completion date of September 3, 2025. The award, made on August 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation applied. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at approximately $22.4K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit in 6 milliliter units. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 9, 2025, and carries no set-aside designation. This award represents a direct fulfillment transaction under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $14,910.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit in 6ml units. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a discrete task order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The company...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,727.51 by the Defense Logistics Agency (DLA) on August 13, 2025. The contract calls for delivery of a Photrexa Cross-Linking Kit (6ml), a specialized pharmaceutical product, with an ultimate completion date of September 4, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to...
- The Defense Logistics Agency has awarded a delivery order valued at $11,182.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the provision of Photrexa Cross-Linking Kit 6ml. This delivery order, issued on August 22, 2025, carries a firm fixed price and an ultimate completion date of September 15, 2025. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a delivery order under the SPE2DB program with the Defense Logistics Agency (DLA). The $16,597.10 firm fixed-price contract is for the supply of the PHOTREXA CROSS-LINKING KIT 6ML medical product. DMS Pharmaceutical Group is a key supplier of a wide range of pharmaceutical items, including branded and generic drugs, biologics, and medical consumables, to support the...
- The Defense Logistics Agency awarded a delivery order valued at $3,727.51 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of PHOTREXA Cross-Linking Kit 6ML. This firm fixed-price delivery order was issued on August 11, 2025, with an ultimate completion date of September 2, 2025, with no set-aside designation applied. The product will be delivered to Park Ridge, IL, where the vendor is headquartered. This...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, is a delivery order valued at $9,855.93 for the supply of the "PHOTREXA CROSS-LINKING KIT 6ML" pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 7, 2023. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,182.53, is for the delivery of pharmaceutical products, including the PHOTREXA CROSS-LINKING KIT 6ML. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 22, 2025. DMS Pharmaceutical Group Inc. has a significant single-award Indefinite...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $9,855.93, is for the delivery of the Photrexa Cross-Linking Kit 6ML pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the Defense Logistics Agency under the SPE2DB program, which has a...
- SPE2DB22D9143Indefinite Delivery Contract
- SPE2DB22D9143-SPE2DB25FZC64Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $44.73 thousand by the Defense Logistics Agency (DLA) for the supply of Photrexa Cross-Linking Kit in 6ML units. This firm fixed-price delivery order, issued on August 29, 2025, is scheduled for completion by September 22, 2025, with performance taking place at the contractor's Park Ridge facility. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market based on its established capabilities as a federal pharmaceutical supplier. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500 million and valid through November 2026. Under this SPE2DB program vehicle, the DLA can issue firm fixed-price delivery orders for comprehensive pharmaceutical products supporting military healthcare facilities worldwide. Photrexa, a corneal cross-linking treatment, represents the type of specialized pharmaceutical product the contractor regularly supplies to Department of Defense healthcare sites. The company's federal contract portfolio demonstrates consistent success in securing pharmaceutical supply agreements with the DLA, positioning it as a critical vendor within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $44.7k | 8/29/25 |